Indiana Medicaid To Cover GLP-1 Obesity Medications Through Federal BALANCE Model

On July 30, 2026, Indiana announced that Medicaid will expand access to select glucagon-like peptide-1 (GLP-1) medications for eligible beneficiaries living with obesity through the federal Better Approaches to Lifestyle and Nutrition for Comprehensive Health (BALANCE) Model. Under the model, participating pharmaceutical manufacturers will make select GLP-1 medications available to Indiana Medicaid for $245 per member per month. After the federal contribution, Indiana’s share will be $85.16 per member per month. FSSA has not yet announced eligibility criteria or an implementation date and said additional details will be released after its agreement with the . . .